Fusion Antibodies (LSE:FAB) Gross-Profit-to-Asset % : 32.93% (As of Sep. 2024)

Fusion Antibodies Gross-Profit-to-Asset % Chart

Fusion Antibodies Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
Gross-Profit-to-Asset %		Get a 7-Day Free Trial					28.85	34.10	45.90	16.45	-2.01

Fusion Antibodies Semi-Annual Data
	Mar15	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial													27.29	-2.18	-8.16	3.48	32.93

Competitive Comparison of Fusion Antibodies's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Fusion Antibodies's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fusion Antibodies's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fusion Antibodies's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Fusion Antibodies's Gross-Profit-to-Asset % falls into.

Fusion Antibodies Gross-Profit-to-Asset % Calculation

Fusion Antibodies's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Fusion Antibodies's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Sep. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Fusion Antibodies Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Fusion Antibodies's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Fusion Antibodies Business Description